9.42
price up icon3.40%   0.31
after-market アフターアワーズ: 9.52 0.10 +1.06%
loading
前日終値:
$9.11
開ける:
$9.38
24時間の取引高:
5.02M
Relative Volume:
1.39
時価総額:
$1.17B
収益:
$631.73M
当期純損益:
$-239.78M
株価収益率:
-4.6634
EPS:
-2.02
ネットキャッシュフロー:
$-33.45M
1週間 パフォーマンス:
-1.15%
1か月 パフォーマンス:
+16.30%
6か月 パフォーマンス:
-40.64%
1年 パフォーマンス:
-58.19%
1日の値動き範囲:
Value
$9.21
$9.83
1週間の範囲:
Value
$8.945
$9.83
52週間の値動き範囲:
Value
$6.78
$24.76

10 X Genomics Inc Stock (TXG) Company Profile

Name
名前
10 X Genomics Inc
Name
セクター
Healthcare (1170)
Name
電話
(925) 401-7300
Name
住所
6230 STONERIDGE MALL ROAD, PLEASANTON, CA
Name
職員
1,306
Name
Twitter
@10xgenomics
Name
次回の収益日
2024-10-31
Name
最新のSEC提出書
Name
TXG's Discussions on Twitter

TXG を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Health Information Services icon
TXG
10 X Genomics Inc
9.42 1.17B 631.73M -239.78M -33.45M -2.02
Health Information Services icon
VEEV
Veeva Systems Inc
285.36 45.71B 2.86B 780.66M 1.20B 4.72
Health Information Services icon
TEM
Tempus Ai Inc
62.07 9.42B 803.32M -709.10M -212.68M -7.8003
Health Information Services icon
DOCS
Doximity Inc
58.85 9.78B 550.17M 201.35M 232.07M 1.00
Health Information Services icon
HQY
Healthequity Inc
111.55 8.70B 1.15B 96.70M -161.99M 1.09
Health Information Services icon
WAY
Waystar Holding Corp
41.16 6.92B 906.14M -52.62M 89.62M -0.3621

10 X Genomics Inc Stock (TXG) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-02-13 ダウングレード Leerink Partners Outperform → Market Perform
2024-09-03 開始されました Leerink Partners Outperform
2024-07-22 アップグレード Jefferies Hold → Buy
2024-07-18 ダウングレード JP Morgan Overweight → Neutral
2024-07-10 ダウングレード Deutsche Bank Buy → Hold
2024-06-27 ダウングレード Wolfe Research Outperform → Peer Perform
2024-06-25 ダウングレード Guggenheim Buy → Neutral
2024-06-03 再開されました Jefferies Hold
2024-05-01 ダウングレード TD Cowen Buy → Hold
2023-12-14 開始されました Guggenheim Buy
2023-12-13 開始されました Wolfe Research Outperform
2023-12-12 アップグレード BofA Securities Underperform → Neutral
2023-07-05 再開されました JP Morgan Overweight
2023-05-10 開始されました Barclays Overweight
2023-03-31 開始されました Stephens Overweight
2023-02-02 開始されました UBS Neutral
2022-12-14 開始されました Deutsche Bank Buy
2022-08-18 ダウングレード Goldman Neutral → Sell
2022-07-25 開始されました Canaccord Genuity Buy
2022-07-15 ダウングレード BofA Securities Neutral → Underperform
2022-07-15 ダウングレード William Blair Outperform → Mkt Perform
2021-10-15 再開されました Cowen Outperform
2021-09-14 ダウングレード BofA Securities Buy → Neutral
2021-03-15 開始されました William Blair Outperform
2020-12-02 開始されました Goldman Neutral
2020-09-09 開始されました Morgan Stanley Overweight
2020-07-10 開始されました Stifel Buy
2020-03-05 開始されました Guggenheim Buy
2020-01-07 開始されました Citigroup Buy
2019-10-07 開始されました BofA/Merrill Buy
2019-10-07 開始されました Cowen Outperform
2019-10-07 開始されました JP Morgan Overweight
2019-09-24 開始されました Evercore ISI Outperform
すべてを表示

10 X Genomics Inc (TXG) 最新ニュース

pulisher
Jun 04, 2025

Forecasting The Future: 7 Analyst Projections For 10x Genomics - Benzinga

Jun 04, 2025
pulisher
Jun 04, 2025

Long Read Sequencing Market Key Players Analysis10X Genomics, - openPR.com

Jun 04, 2025
pulisher
Jun 04, 2025

10x Genomics, Inc. (NASDAQ:TXG) Stock Holdings Increased by Deutsche Bank AG - Defense World

Jun 04, 2025
pulisher
Jun 03, 2025

ARK Investment Acquires 290K Shares of 10x Genomics (TXG) | TXG Stock News - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

10x Genomics, Inc. (TXG) Stock Analysis: Evaluating the 31.90% Potential Upside - DirectorsTalk Interviews

Jun 03, 2025
pulisher
Jun 02, 2025

Cathie Wood's ARK Investment Acquires Significant Stake in 10x G - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

Layoff Tracker: Keros Cuts 45% of Workforce Along With Pulmonary Hypertension Drug - BioSpace

Jun 02, 2025
pulisher
Jun 01, 2025

10 Best Healthcare Stocks to Invest In (June 2025) - Securities.io

Jun 01, 2025
pulisher
May 31, 2025

ARK Investment Acquires 342K Shares of 10x Genomics (TXG) | TXG Stock News - GuruFocus

May 31, 2025
pulisher
May 31, 2025

Cetera Investment Advisers Raises Stake in 10x Genomics, Inc. (NASDAQ:TXG) - Defense World

May 31, 2025
pulisher
May 30, 2025

Cathie Wood’s ARK buys Intellia, 10x Genomics, sells Tesla stock By Investing.com - Investing.com Nigeria

May 30, 2025
pulisher
May 30, 2025

Cathie Wood’s ARK buys Intellia, 10x Genomics, sells Tesla stock - Investing.com

May 30, 2025
pulisher
May 30, 2025

10x Genomics, Inc. (NASDAQ:TXG) Given Average Recommendation of “Hold” by Analysts - Defense World

May 30, 2025
pulisher
May 27, 2025

Powell, Mayville Engineering, Graham Corporation, Hyster-Yale Materials Handling, and 10x Genomics Shares Skyrocket, What You Need To Know - Yahoo Finance

May 27, 2025
pulisher
May 27, 2025

Shareholders May Be Wary Of Increasing 10x Genomics, Inc.'s (NASDAQ:TXG) CEO Compensation Package - simplywall.st

May 27, 2025
pulisher
May 27, 2025

10x Genomics, Inc. (TXG) Stock Analysis: A 52.56% Potential Upside Amidst a Challenging Market - DirectorsTalk Interviews

May 27, 2025
pulisher
May 27, 2025

10x Genomics’ (TXG) “Sell (E+)” Rating Reiterated at Weiss Ratings - Defense World

May 27, 2025
pulisher
May 25, 2025

10x Genomics, Inc. (NASDAQ:TXG) Shares Sold by Bank of America Corp DE - Defense World

May 25, 2025
pulisher
May 23, 2025

Why 10x Genomics Stock Was Sliding This Week - Barchart.com

May 23, 2025
pulisher
May 23, 2025

10x Genomics Reports Third Quarter 2023 Financial Results - Seeking Alpha

May 23, 2025
pulisher
May 22, 2025

10x Genomics Reports First Quarter 2024 Financial Results - Seeking Alpha

May 22, 2025
pulisher
May 21, 2025

Gotham Asset Management LLC Takes $264,000 Position in 10x Genomics, Inc. (NASDAQ:TXG) - Defense World

May 21, 2025
pulisher
May 21, 2025

10x Genomics (TXG) Upgraded to Buy: Here's What You Should Know - Yahoo Finance

May 21, 2025
pulisher
May 20, 2025

10x Genomics (NASDAQ:TXG) Price Target Lowered to $18.00 at Morgan Stanley - Defense World

May 20, 2025
pulisher
May 20, 2025

10x Genomics (NASDAQ:TXG) Shares Down 4.8% Following Analyst Downgrade - Defense World

May 20, 2025
pulisher
May 19, 2025

High-Throughput Transcriptomics 2025–2028: Next-Gen Breakthroughs Set to Disrupt Genomics Market - macnifico.pt

May 19, 2025
pulisher
May 19, 2025

10x Genomics (TXG) Price Target Lowered by Morgan Stanley | TXG Stock News - GuruFocus

May 19, 2025
pulisher
May 19, 2025

10x Genomics, Inc. (NASDAQ:TXG) Shares Sold by Northern Trust Corp - Defense World

May 19, 2025
pulisher
May 17, 2025

Stephens Reaffirms Overweight Rating for 10x Genomics (NASDAQ:TXG) - Defense World

May 17, 2025
pulisher
May 16, 2025

'Shooting ourselves in the foot': Trump administration cuts force East Bay’s 10x Genomics into layoffs - The Business Journals

May 16, 2025
pulisher
May 16, 2025

Dimensional Fund Advisors LP Sells 23,956 Shares of 10x Genomics, Inc. (NASDAQ:TXG) - Defense World

May 16, 2025
pulisher
May 15, 2025

NanoString to pay 10x Genomics $68m in global settlement - Life Sciences Intellectual Property Review

May 15, 2025
pulisher
May 15, 2025

10x Genomics reaches settlement with Bruker - Medical Buyer

May 15, 2025
pulisher
May 15, 2025

Stifel Financial Corp Raises Holdings in 10x Genomics, Inc. (NASDAQ:TXG) - Defense World

May 15, 2025
pulisher
May 15, 2025

UBS Group Lowers 10x Genomics (NASDAQ:TXG) Price Target to $12.00 - Defense World

May 15, 2025
pulisher
May 14, 2025

10x Genomics Reaches $68 Million Patent Settlement With Bruker - marketscreener.com

May 14, 2025
pulisher
May 14, 2025

10x Genomics Settles Litigation with Bruker Corporation - TipRanks

May 14, 2025
pulisher
May 14, 2025

10x Genomics settles patent dispute with Bruker for $68 million - Investing.com

May 14, 2025
pulisher
May 14, 2025

10x Genomics Announces Patent Litigation Settlement Agreement with Bruker - Financial Times

May 14, 2025
pulisher
May 14, 2025

All Ongoing Lawsuits Between Bruker And 10X Genomics To Be Withdrawn - marketscreener.com

May 14, 2025
pulisher
May 14, 2025

Earnings Release: Here's Why Analysts Cut Their 10x Genomics, Inc. (NASDAQ:TXG) Price Target To US$12.96 - simplywall.st

May 14, 2025
pulisher
May 14, 2025

10x Genomics (TXG) Price Target Reduced by UBS Amid Funding Chal - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Bruker and 10x Genomics settle patent dispute - Yahoo Finance

May 14, 2025
pulisher
May 13, 2025

10x Genomics, Bruker Strike Deal After $31M Patent Verdict - Law360

May 13, 2025
pulisher
May 13, 2025

10x Genomics (TXG) Sees Price Target Lowered by UBS | TXG Stock News - GuruFocus

May 13, 2025
pulisher
May 13, 2025

UPC battle between 10x Genomics and Curio Bioscience moves to next stage - JUVE Patent

May 13, 2025
pulisher
May 13, 2025

UBS Adjusts Price Target on 10x Genomics to $12 From $14, Maintains Neutral Rating - marketscreener.com

May 13, 2025
pulisher
May 13, 2025

Canaccord Adjusts 10x Genomics (TXG) Price Target Citing Market Uncertainty | TXG Stock News - GuruFocus

May 13, 2025
pulisher
May 13, 2025

10x Genomics (TXG) Price Target Reduced by UBS Amid Funding Challenges | TXG Stock News - GuruFocus

May 13, 2025
pulisher
May 13, 2025

10x Genomics (NASDAQ:TXG) Price Target Lowered to $6.50 at The Goldman Sachs Group - Defense World

May 13, 2025
pulisher
May 13, 2025

10x Genomics (NASDAQ:TXG) Price Target Cut to $15.00 by Analysts at Canaccord Genuity Group - Defense World

May 13, 2025

10 X Genomics Inc (TXG) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$11.76
price up icon 0.51%
$22.93
price down icon 0.80%
$23.19
price up icon 1.71%
$38.89
price up icon 1.01%
$24.11
price up icon 2.60%
health_information_services WAY
$41.16
price up icon 2.67%
大文字化:     |  ボリューム (24 時間):